Dietary Supplements for Endometriosis-Associated Pain: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials
Gynecologic and Obstetric Investigation · 26.04.2025 · 91 (1) · 101-114
DOI: 10.1159/000545414 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Gynecologic and Obstetric Investigation, online erschienen am 26.04.2025. Verfasst von Noemi Salmeri und 5 weiteren Autor:innen. Beteiligte Einrichtung: Academic Center for Research on Adenomyosis and Endometriosis, Department of Clinical Sciences and Community Health, University of Milan, Milan, Ital…. Hauptthemen laut MEDLINE: Endometriosis, Dietary Supplements, Pelvic Pain. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
In recent years, dietary supplements have emerged as popular “natural” alternatives to conventional pharmacological treatments for various conditions, including endometriosis. The growing popularity of supplements for endometriosis-associated pain, fueled by an expanding and minimally regulated market, underscores the need for robust evidence of efficacy, as a prerequisite for any consideration on effectiveness. This meta-analysis synthesizes evidence from randomized, placebo-controlled trials (RCTs), the gold standard in evidence-based medicine, to assess the efficacy of dietary supplements in endometriosis-associated pain.
Methods
A systematic search of PubMed, Embase, Scopus, and the Cochrane Library was conducted up to November 5, 2024, in adherence to PRISMA 2020 guidelines. Two independent reviewers screened studies using PICOS criteria: reproductive-age women with endometriosis (Population), dietary supplements (Intervention), placebo (Comparator), and pain-related outcomes (Outcomes), assessed in placebo-controlled RCTs adhering to CONSORT standards (Study type). Three pain domains were evaluated: (i) symptom severity (visual analogue scale [VAS] for pelvic pain, dysmenorrhea, dyspareunia), (ii) pain catastrophizing, and (iii) quality of life, as measured by the Short Form-12 Health Survey (SF-12) and the Endometriosis Health Profile-30 (EHP-30). Risk of bias was assessed using the Cochrane RoB2 tool. Random-effects models were used to calculate pooled mean differences (MDs) and 95% confidence intervals (CIs). Statistical heterogeneity was assessed with the I2 statistic, and subgroup analyses explored clinically relevant confounders. Sensitivity analyses excluded studies with conflicts of interest or trustworthiness issues, as defined by the Obstetrics and Gynecology Editors’ Integrity Group (OGEIG). Publication bias was evaluated using Egger’s test, Begg’s test, and the trim-and-fill method. All analyses were conducted using STATA version 18.
Results
Nine RCTs (n = 545 subjects; 274 in the treatment group and 271 in the placebo group) were included. Only three met the “absolute” OGEIG trustworthiness criteria. No significant differences were observed between supplements and placebo for pelvic pain (pooled MD: −1.1; 95% CI: −3.0 to 0.8; I2 = 96.1%), dysmenorrhea (pooled MD: −2.0; 95% CI: −4.4 to 0.5; I2 = 93.8%), or dyspareunia (pooled MD: −2.0; 95% CI: −4.9 to 0.9; I2 = 96.5%). These findings remained consistent when the analysis was restricted to studies without conflicts of interest, those authored by researchers with no retractions, and those meeting OGEIG trustworthiness criteria. Subgroup analyses reduced heterogeneity and confirmed no significant benefits. Pain catastrophizing and quality-of-life measures showed little to no improvement.
Conclusion
While limited evidence precludes definitive conclusions about specific dietary supplements, available data suggest they lack efficacy for managing endometriosis-associated pain. Given the absence of demonstrated benefits, along with potential harms and costs, dietary supplements should not be recommended at this time for managing endometriosis-related pain.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Academic Center for Research on Adenomyosis and Endometriosis, Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy, noemi.salmeri@unimi.it.
- Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy, noemi.salmeri@unimi.it.
- Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
- Academic Center for Research on Adenomyosis and Endometriosis, Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.
Zitieren
APA
Salmeri, N., Ragusi, A., Buffo, C., Somigliana, E., Viganò, P., & Vercellini, P. (2025). Dietary Supplements for Endometriosis-Associated Pain: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials. Gynecologic and Obstetric Investigation, 91(1), 101-114. https://doi.org/10.1159/000545414
Vancouver
Salmeri N, Ragusi A, Buffo C, Somigliana E, Viganò P, Vercellini P. Dietary Supplements for Endometriosis-Associated Pain: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials. Gynecologic and Obstetric Investigation. 2025;91(1):101-114. doi:10.1159/000545414
BibTeX
@article{Salmeri2025,
author = {Salmeri, Noemi and Ragusi, Alessia and Buffo, Camilla and Somigliana, Edgardo and Viganò, Paola and Vercellini, Paolo},
title = {Dietary Supplements for Endometriosis-Associated Pain: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials},
journal = {Gynecologic and Obstetric Investigation},
year = {2025},
volume = {91},
number = {1},
pages = {101--114},
doi = {10.1159/000545414}
}
EUVIMED